Early Psychological Intervention After Rape
Launched by ST. OLAVS HOSPITAL · Aug 3, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how an early psychological treatment called modified Prolonged Exposure Therapy (mPE) can help women who have experienced rape. Many women develop post-traumatic stress disorder (PTSD) after such traumatic events, and this study aims to see if starting therapy soon after the incident can prevent PTSD from developing. The trial will involve women aged 16 and older who have faced sexual violence and are seeking help at specific sexual assault care centers in Norway. Participants will be randomly assigned to either receive the mPE therapy or the usual care that is typically provided.
If you or someone you know is eligible to participate, you can expect to attend three to five therapy sessions, which will last about an hour each. The study is currently recruiting participants, and it’s important to note that certain conditions would exclude someone from joining, such as being under 16 years old, having severe mental health issues, or currently undergoing treatment for PTSD. The goal is to better understand how early intervention can support recovery after such a traumatic experience.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women ≥ 16 years of age
- • attending after a trauma meeting the DSM V trauma definition criterion "sexual violation" (in this context, characterized by penetration in any body orifice, by penis, finger, foreign body, but also attempted penetration leading to a sufficient mental reaction, helplessness, without control, intense fear etc.)
- Exclusion Criteria:
- • Age \< 16 years
- • male biological gender
- • cognitive disability
- • acute psychosis
- • acute suicidal
- • severe alcohol/drug abuse
- • current treatment for PTSD
- • non-Norwegian speaking
- • total amnesia for the event
About St. Olavs Hospital
St. Olavs Hospital is a leading healthcare institution located in Trondheim, Norway, renowned for its commitment to advancing medical research and improving patient care. As a key clinical trial sponsor, the hospital is dedicated to conducting innovative research across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With state-of-the-art facilities and a patient-centric approach, St. Olavs Hospital aims to enhance clinical outcomes and contribute to the global body of medical knowledge through rigorous and ethically conducted clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fredrikstad, , Norway
Oslo, , Norway
Sandefjord, , Norway
Trondheim, , Norway
Stavanger, In, Norway
Patients applied
Trial Officials
Cecilie T Hagemann
Principal Investigator
St. Olavs Hospital
Joar Ø Halvorsen
Study Director
St. Olavs Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials